/BINP
BINP Stock - Bionoid Pharma, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.03-46.95%
$0.02 (-46.95%) • Dec 12
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.04
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BINP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.03 – $0.03
TARGET (TP)$0.04
STOP LOSS$0.03
RISK/REWARD1:2.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-4.66
52W High$0.45
52W Low$0.02
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $37,506 | $36,041 | $102,120 | $30,657 |
| Gross Profit | $-276,571 | $8,417 | $17,348 | $46,010 | $14,072 |
| Gross Margin | N/A | 22.4% | 48.1% | 45.1% | 45.9% |
| Operating Income | $-276,571 | $13,499 | $1,860 | $-79,831 | $-32,480 |
| Net Income | $-317,000 | $11,725 | $1,478 | $-135,000 | $-455,783 |
| Net Margin | N/A | 31.3% | 4.1% | -132.2% | -1486.7% |
| EPS | $-0.01 | $-0.00 | $0.00 | $-0.00 | $-11.88 |
Company Overview
Bionoid Pharma, Inc. operates as a medical device company. It develops and markets innovative medical devices and technologies for the orthopedic and pain management markets. The company was founded on October 20, 1997 and is headquartered in Beverly Hills, CA.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BINPBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q2 2023
EPS Surprise History
Q1 11
No data
Q3 12
No data
Q1 21
No data
Q2 21
No data
Q3 21
No data
Q4 21
No data
Q4 22
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2023 | Jun 30, 2023 | — | $0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.88 | — | — |
Q3 2012 | Sep 30, 2012 | — | $8.78 | — | — |
Q1 2011 | Mar 31, 2011 | — | $-0.15 | — | — |
Q4 2010 | Dec 31, 2010 | — | $-0.03 | — | — |
Q3 2010 | Sep 30, 2010 | — | $-0.03 | — | — |
Q2 2010 | Jun 30, 2010 | — | $-0.03 | — | — |
Q1 2010 | Mar 31, 2010 | — | $-0.02 | — | — |
Q4 2009 | Dec 31, 2009 | — | $-0.04 | — | — |
Q3 2009 | Sep 30, 2009 | — | $-0.03 | — | — |
Q2 2009 | Jun 30, 2009 | — | $-0.06 | — | — |
Q2 2009 | May 20, 2009 | — | $-0.50 | — | — |
Q4 2008 | Dec 31, 2008 | — | $-0.02 | — | — |
Q4 2008 | Nov 19, 2008 | — | $-0.50 | — | — |
Q3 2008 | Aug 14, 2008 | — | $-0.50 | — | — |
Q2 2008 | May 15, 2008 | — | $-0.50 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BINP
What is BINP's current stock price?
Bionoid Pharma, Inc. (BINP) is currently trading at $0.03 per share. The stock has moved -46.95% today.
What is the analyst price target for BINP?
No analyst price targets are currently available for this stock.
What sector is Bionoid Pharma, Inc. in?
Bionoid Pharma, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is BINP's market cap?
Bionoid Pharma, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does BINP pay dividends?
No, Bionoid Pharma, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBMCS
BioTech Medics, Inc.
$0.01
Mkt Cap: $0.0B
BMMJ
Body and Mind Inc.
$0.00
Mkt Cap: $0.0B
CBDY
Target Group Inc.
$0.00
Mkt Cap: $0.0B
CTTH
CTT Pharmaceutical Holdings, Inc.
$0.05
Mkt Cap: $0.0B
EDXC
Endexx Corporation
$0.00
Mkt Cap: $0.0B
EXMT
Anything Technologies Media, Inc.
$0.00
Mkt Cap: $0.0B
HBRM
Herborium Group, Inc.
$0.00
Mkt Cap: $0.0B
LVVEF
Yooma Wellness Inc.
$0.00
Mkt Cap: $0.0B
MJNA
Medical Marijuana, Inc.
$0.00
Mkt Cap: $0.0B
SRUTF
Sproutly Canada Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to BINP for comparison